#METABOLOMICS WORKBENCH Fedorova_20240718_071832 DATATRACK_ID:5022 STUDY_ID:ST003364 ANALYSIS_ID:AN005510 PROJECT_ID:PR002090
VERSION             	1
CREATED_ON             	August 1, 2024, 6:37 pm
#PROJECT
PR:PROJECT_TITLE                 	Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in
PR:PROJECT_TITLE                 	fibro-calcific aortic valve disease
PR:PROJECT_SUMMARY               	In-depth lipidomics profiling was performed on human tricuspid and bicuspid
PR:PROJECT_SUMMARY               	aortic valve tissue at different pathological stages, including mildly diseased,
PR:PROJECT_SUMMARY               	fibrotic and calcific tissue sections. Untargeted and targeted analysis were
PR:PROJECT_SUMMARY               	employed to enable high identification coverage and accurate quantification of
PR:PROJECT_SUMMARY               	lipids. Chromatographic separation modes (C18 RPC, C30 RPC) was combined with MS
PR:PROJECT_SUMMARY               	analysis using various acquisition modes (full MS, DDA, SRM) to allow for the
PR:PROJECT_SUMMARY               	identification of 1084 lipid molecular species across 28 lipid subclasses, of
PR:PROJECT_SUMMARY               	which 480 lipids were semi-absolutely quantified.
PR:INSTITUTE                     	Technical University Dresden
PR:LAST_NAME                     	Fedorova
PR:FIRST_NAME                    	Maria
PR:ADDRESS                       	Tatzberg 47/49, Dresden, Saxony, 01307, Germany
PR:EMAIL                         	maria.fedorova@tu-dresden.de
PR:PHONE                         	+49 351 796 36617
#STUDY
ST:STUDY_TITLE                   	Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in
ST:STUDY_TITLE                   	fibro-calcific aortic valve disease
ST:STUDY_SUMMARY                 	In-depth lipidomics profiling was performed on human tricuspid and bicuspid
ST:STUDY_SUMMARY                 	aortic valve tissue at different pathological stages, including mildly diseased,
ST:STUDY_SUMMARY                 	fibrotic and calcific tissue sections. Untargeted and targeted analysis were
ST:STUDY_SUMMARY                 	employed to enable high identification coverage and accurate quantification of
ST:STUDY_SUMMARY                 	lipids. Chromatographic separation modes (C18 RPC, C30 RPC) was combined with MS
ST:STUDY_SUMMARY                 	analysis using various acquisition modes (full MS, DDA, SRM) to allow for the
ST:STUDY_SUMMARY                 	identification of 1084 lipid molecular species across 28 lipid subclasses, of
ST:STUDY_SUMMARY                 	which 480 lipids were semi-absolutely quantified.
ST:INSTITUTE                     	Technical University Dresden
ST:LAST_NAME                     	Fedorova
ST:FIRST_NAME                    	Maria
ST:ADDRESS                       	Tatzberg 47/49, Dresden, Saxony, 01307, Germany
ST:EMAIL                         	maria.fedorova@tu-dresden.de
ST:PHONE                         	+49 351 796 36617
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	F_pool_1.1	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_1.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_pos; Scan_range=250-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_pool_1.2	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_1.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_pos; Scan_range=250-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_pool_1.3	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_1.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_pos; Scan_range=250-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_pool_1.4	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_1.4.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=380-1200; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_pool_1.5	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_1.5.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=380-1200; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_pool_1.6	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_1.6.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=380-1200; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_pool_1.7	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_1.7.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=400-1600; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_pool_1.8	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_1.8.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=400-1600; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_pool_1.9	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_1.9.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=400-1600; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_pool_2.1	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_2.1.mzML; LC_method=C30, 57 min; MS_method=Exploris_DDA_pos; Scan_range=200-1200; Injection_Volume=2.5
SUBJECT_SAMPLE_FACTORS           	-	F_pool_2.2	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_2.2.mzML; LC_method=C30, 57 min; MS_method=Exploris_DDA_pos; Scan_range=200-1200; Injection_Volume=2.5
SUBJECT_SAMPLE_FACTORS           	-	F_pool_2.3	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_2.3.mzML; LC_method=C30, 57 min; MS_method=Exploris_DDA_pos; Scan_range=200-1200; Injection_Volume=2.5
SUBJECT_SAMPLE_FACTORS           	-	F_pool_2.4	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_2.4.mzML; LC_method=C30, 57 min; MS_method=Exploris_DDA_neg; Scan_range=370-1480; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_pool_2.5	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_2.5.mzML; LC_method=C30, 57 min; MS_method=Exploris_DDA_neg; Scan_range=200-1400; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_pool_2.6	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_pool_2.6.mzML; LC_method=C30, 57 min; MS_method=Exploris_DDA_neg; Scan_range=370-1480; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_0.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS1 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_0.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_0.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS2 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_0.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_0.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS3 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_0.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_1.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS4 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_1.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_1.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS5 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_1.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_1.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS6 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_1.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_2.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS7 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_2.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_2.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS8 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_2.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_2.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS9 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_2.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_3.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS10 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_3.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_3.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS11 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_3.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_3.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS12 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_3.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_4.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS13 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_4.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_4.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS14 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_4.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_4.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS15 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_4.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_5.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS16 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_5.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_5.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS17 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_5.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_5.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS18 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_5.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_6.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS19 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_6.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_6.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS20 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_6.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-p_6.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS21 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-p_6.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_pos; Scan_range=100-1500; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_0.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS22 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_0.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_0.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS23 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_0.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_0.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS24 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_0.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_1.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS25 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_1.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_1.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS26 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_1.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_1.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS27 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_1.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_2.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS28 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_2.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_2.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS29 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_2.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_2.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS30 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_2.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_3.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS31 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_3.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_3.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS32 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_3.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_3.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS33 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_3.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_4.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS34 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_4.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_4.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS35 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_4.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_4.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS36 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_4.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_5.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS37 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_5.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_5.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS38 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_5.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_5.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS39 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_5.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_6.1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS40 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_6.1.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_6.2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS41 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_6.2.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal-n_6.3	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS42 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal-n_6.3.mzML; LC_method=C30, 34 min; MS_method=QEx_MS1_neg; Scan_range=100-1500; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	F_cal_tQC1	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS43 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal_tQC1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_pos; Scan_range=250-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_cal_tQC2	Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS44 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_cal_tQC2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=150-1800; Injection_Volume=10
SUBJECT_SAMPLE_FACTORS           	-	A_cal_tQC1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal_tQC1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal_tQC2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal_tQC2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal_tQC3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal_tQC3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_0.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_0.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_0.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_0.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_0.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_0.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_1.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_1.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_1.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_1.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_1.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_1.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_2.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_2.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_2.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_2.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_2.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_2.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_3.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_3.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_3.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_3.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_3.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_3.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_4.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_4.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_4.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_4.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_4.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_4.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_5.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_5.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_5.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_5.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_5.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_5.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_6.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_6.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_6.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_6.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal1_6.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal1_6.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_0.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_0.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_0.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_0.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_0.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_0.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_1.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_1.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_1.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_1.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_1.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_1.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_2.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_2.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_2.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_2.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_2.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_2.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_3.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_3.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_3.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_3.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_3.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_3.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_4.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_4.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_4.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_4.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_4.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_4.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_5.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_5.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_5.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_5.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_5.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_5.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_6.1	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_6.1.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_6.2	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_6.2.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_cal2_6.3	Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_cal2_6.3.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_0.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_0.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_0.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_0.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_0.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_0.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_1.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_1.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_1.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_1.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_1.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_1.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_2.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_2.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_2.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_2.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_2.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_2.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_3.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_3.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_3.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_3.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_PRE_pool_3.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_PRE_pool_3.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_0.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_0.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_0.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_0.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_0.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_0.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_1.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_1.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_1.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_1.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_1.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_1.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_2.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_2.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_2.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_2.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_2.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_2.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_3.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_3.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_3.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_3.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_PRE_pool_3.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_PRE_pool_3.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_POST_pool_1.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_POST_pool_1.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_POST_pool_1.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_POST_pool_1.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_POST_pool_1.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_POST_pool_1.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_POST_pool_2.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_POST_pool_2.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_POST_pool_2.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_POST_pool_2.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_POST_pool_2.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_POST_pool_2.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_POST_pool_3.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_POST_pool_3.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_POST_pool_3.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_POST_pool_3.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	A_POST_pool_3.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_POST_pool_3.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_POST_pool_1.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_POST_pool_1.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_POST_pool_1.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_POST_pool_1.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_POST_pool_1.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_POST_pool_1.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_POST_pool_2.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_POST_pool_2.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_POST_pool_2.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_POST_pool_2.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_POST_pool_2.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_POST_pool_2.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_POST_pool_3.1	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_POST_pool_3.1.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_POST_pool_3.2	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_POST_pool_3.2.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_POST_pool_3.3	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_POST_pool_3.3.mzML; LC_method=C30, 34 min; MS_method=QEx_DDA_neg; Scan_range=200-1200; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_01	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_01.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_BQC1	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_BQC1.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_BQC2	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_BQC2.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_BQC3	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_BQC3.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_BQC4	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_BQC4.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_BQC5	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_BQC5.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_BQC6	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_BQC6.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_1.1	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_1.1.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_1.2	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_1.2.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_1.3	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_1.3.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_1.4	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_1.4.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_1.5	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_1.5.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_1.6	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_1.6.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_1.7	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_1.7.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_02	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_02.mzML; LC_method=C30, 47 min; MS_method=Exploris_DDA_pos; Scan_range=200-1200; Injection_Volume=2.5
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_03	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_03.mzML; LC_method=C30, 47 min; MS_method=Exploris_DDA_neg; Scan_range=200-1400; Injection_Volume=5
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_04	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_04.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M03	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M03.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F08	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F08.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F28	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F28.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C35	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C35.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C27	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C27.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F19	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F19.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M08	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M08.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_05	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_05.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C17	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C17.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M20	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M20.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F18	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F18.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C28	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C28.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F26	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F26.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C13	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C13.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_06	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_06.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C08	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C08.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F11	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F11.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F24	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F24.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F29	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F29.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F34	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F34.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M14	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M14.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F13	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F13.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F37	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F37.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C07	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C07.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_07	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_07.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F35	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F35.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C16	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C16.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C05	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C05.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C12	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C12.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C02	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C02.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C15	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C15.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M09	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M09.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_08	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_08.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F32	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F32.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F25	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F25.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C18	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C18.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C19	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C19.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F20	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F20.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F31	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F31.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C33	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C33.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_09	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_09.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C21	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C21.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C34	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C34.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M13	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M13.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M01	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M01.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_10	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_10.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C09	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C09.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F05	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F05.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C25	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C25.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F16	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F16.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F15	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F15.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C23	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C23.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M06	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M06.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C30	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C30.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C01	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C01.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_11	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_11.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F06	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F06.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F17	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F17.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M17	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M17.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M18	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M18.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M21	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M21.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C29	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C29.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F21	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F21.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_12	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_12.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F12	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F12.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C26	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C26.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C24	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C24.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C20	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C20.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F36	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F36.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F14	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F14.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_13	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_13.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M15	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M15.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C11	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C11.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C31	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C31.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M05	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M05.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M19	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M19.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M10	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M10.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_14	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_14.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F03	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F03.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F23	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F23.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C03	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C03.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M16	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M16.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F04	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F04.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F30	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F30.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F09	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F09.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F27	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F27.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F07	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F07.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C14	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C14.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_15	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_15.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F10	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F10.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F01	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F01.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C10	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C10.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C22	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C22.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M04	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M04.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M02	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M02.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M11	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M11.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_16	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_16.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C06	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C06.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C04	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C04.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F33	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F33.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_C32	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_Ex_C32.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M07	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M07.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F02	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F02.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_17	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_17.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M22	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M22.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_F22	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_Ex_F22.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_M12	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_Ex_M12.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	F_Ex_tQC_18	Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_Ex_tQC_18.mzML; LC_method=C30, 47 min; MS_method=Exploris_MS1_pos; Scan_range=200-1200; Injection_Volume=2
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_01	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_01.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_02	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_02.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_03	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_03.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_04	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_04.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_05	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_05.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_BQC07	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_BQC07.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_BQC08	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_BQC08.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_BQC09	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_BQC09.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F49	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F49.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C40	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C40.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F38	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F38.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C36	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C36.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F39	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F39.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M32	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M32.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F46	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F46.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M27	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M27.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C45	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C45.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M36	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M36.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M34	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M34.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_06	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_06.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F50	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F50.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F43	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F43.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M35	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M35.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M30	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M30.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F47	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F47.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F48	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F48.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F51	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F51.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C47	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C47.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C37	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C37.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M33	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M33.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C41	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C41.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M29	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M29.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C46	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C46.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F41	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F41.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F42	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F42.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_07	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_07.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M31	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M31.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M37	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M37.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F45	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F45.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C44	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C44.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M26	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M26.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_M28	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=A_TSQ_M28.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C43	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C43.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F40	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F40.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C38	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C38.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C42	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C42.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_F44	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=A_TSQ_F44.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C39	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C39.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_C48	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=A_TSQ_C48.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_BQC01	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_TSQ_BQC01.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_BQC02	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_TSQ_BQC02.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_08	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_08.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_BQC03	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_TSQ_BQC03.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_BQC04	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_TSQ_BQC04.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_BQC05	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_TSQ_BQC05.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_BQC06	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=F_TSQ_BQC06.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M03	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M03.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F08	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F08.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F28	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F28.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C35	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C35.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C27	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C27.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C10	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C10.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M08	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M08.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_09	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_09.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C17	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C17.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M20	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M20.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F19	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F19.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C28	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C28.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F26	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F26.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C13	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C13.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C08	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C08.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F12	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F12.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F24	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F24.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F29	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F29.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F34	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F34.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_10	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_10.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F11	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F11.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F14	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F14.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F37	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F37.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C07	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C07.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F35	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F35.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C16	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C16.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C05	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C05.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M12	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M12.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C12	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C12.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C02	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C02.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C15	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C15.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M09	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M09.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_11	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_11.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F32	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F32.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F25	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F25.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C18	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C18.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C19	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C19.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F20	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F20.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F31	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F31.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C33	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C33.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C21	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C21.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C34	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C34.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_12	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_12.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M01	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M01.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C09	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C09.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F05	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F05.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C25	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C25.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F16	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F16.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C23	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C23.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M06	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M06.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C30	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C30.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C01	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C01.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_13	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_13.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F06	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F06.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F18	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F18.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M17	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M17.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M18	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M18.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M21	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M21.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C29	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C29.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F21	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F21.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F13	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F13.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F17	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F17.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C26	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C26.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C24	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C24.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_14	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_14.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M11	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M11.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C20	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C20.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F36	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F36.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F15	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F15.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M15	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M15.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C11	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C11.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C31	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C31.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M05	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M05.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M19	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M19.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M10	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M10.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_15	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_15.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F03	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F03.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F23	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F23.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C03	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C03.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M16	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M16.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F04	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F04.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F30	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F30.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F09	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F09.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F27	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F27.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F07	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F07.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C14	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C14.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F10	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F10.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F01	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F01.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_16	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_16.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C22	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C22.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M04	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M04.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M02	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M02.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C06	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C06.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C04	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C04.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F33	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F33.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_C32	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific	RAW_FILE_NAME(Raw_file_names)=F_TSQ_C32.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M07	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M07.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F02	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F02.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M14	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M14.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_17	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_17.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M22	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M22.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_F22	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic	RAW_FILE_NAME(Raw_file_names)=F_TSQ_F22.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	F_TSQ_M13	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased	RAW_FILE_NAME(Raw_file_names)=F_TSQ_M13.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
SUBJECT_SAMPLE_FACTORS           	-	A_TSQ_tQC_18	Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	RAW_FILE_NAME(Raw_file_names)=A_TSQ_tQC_18.mzML; LC_method=C18, 15 min; MS_method=TSQ_SRM_neg; Scan_range=SRM; Injection_Volume=3
#COLLECTION
CO:COLLECTION_SUMMARY            	CAVD tissues were obtained from 55 patients undergoing aortic valve replacement
CO:COLLECTION_SUMMARY            	for severe aortic stenosis. For all human tissue samples used in this study,
CO:COLLECTION_SUMMARY            	tissue collection was approved by the local Ethical Committee (Medical Faculty,
CO:COLLECTION_SUMMARY            	University Leipzig, registration number 128/19-ek) and all patients gave written
CO:COLLECTION_SUMMARY            	informed consent in accordance with the Declaration of Helsinki. All samples
CO:COLLECTION_SUMMARY            	showed macroscopic calcification as a sign of progressed FCAVD. Tissue samples
CO:COLLECTION_SUMMARY            	were dissected into mildly diseased, fibrotic and calcific pieces on-site and
CO:COLLECTION_SUMMARY            	flash frozen in liquid nitrogen. The deep frozen tissue sections were crushed
CO:COLLECTION_SUMMARY            	into a thin powder in a percussion mortar in liquid nitrogen and stored at
CO:COLLECTION_SUMMARY            	-80°C until further analysis.
CO:SAMPLE_TYPE                   	Aortic valve tissue
CO:COLLECTION_LOCATION           	Leipzig, Germany
CO:STORAGE_CONDITIONS            	-80?
CO:STORAGE_VIALS                 	Plastic tubes
CO:ADDITIVES                     	none
#TREATMENT
TR:TREATMENT_SUMMARY             	NA
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Aortic valve tissue was spiked with tailored mixtures of internal standards and
SP:SAMPLEPREP_SUMMARY            	lipids were extracted either using the Folch method or by acidified MeOH/CHCl3
SP:SAMPLEPREP_SUMMARY            	lipid extraction.
SP:PROCESSING_STORAGE_CONDITIONS 	4?
SP:EXTRACTION_METHOD             	Folch lipid extraction or acidified MeOH/CHCl3 lipid extraction
SP:EXTRACT_STORAGE               	-80?
SP:SAMPLE_DERIVATIZATION         	none
SP:SAMPLE_SPIKING                	aortic valve tissue specific internal standard mix
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Four liquid chromatography methods were employed to allow optimal lipidome
CH:CHROMATOGRAPHY_SUMMARY        	separation to enhance coverage of lipid species identifications and fast
CH:CHROMATOGRAPHY_SUMMARY        	quantification. All details on the respective methods are provided in the
CH:CHROMATOGRAPHY_SUMMARY        	attached methods document
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Thermo Vanquish
CH:COLUMN_NAME                   	Thermo Accucore C30 (150 x 2.1mm,2.6um)
CH:SOLVENT_A                     	50% acetonitrile/50% water; 5 mM ammonium formate; 0.1% formic acid
CH:SOLVENT_B                     	85% isopropanol/10% acetonitrile/5% water; 5 mM ammonium formate; 0.1% formic
CH:SOLVENT_B                     	acid
CH:FLOW_GRADIENT                 	0-20 min – 10 to 86% B, 20-22 min – 86 to 95% B, 22-26 min – 95% B,
CH:FLOW_GRADIENT                 	26-26.1 min – 95 to 10% B, followed by 7.9 min re-equilibration at 10% B.
CH:FLOW_RATE                     	0.3 mL/min
CH:COLUMN_TEMPERATURE            	50 °C
CH:METHODS_FILENAME              	FCAVD_methods.pdf
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Exploris 240 Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	DDA with with inclusion list for the assessment of PA and LPA recovery rates of
MS:MS_COMMENTS                   	Folch and acidified MeOH/CHCl3 lipid extraction in negative ion mode
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	Peak area
MS_METABOLITE_DATA_START
Samples	A_PRE_pool_0.1	A_PRE_pool_0.2	A_PRE_pool_0.3	A_PRE_pool_1.1	A_PRE_pool_1.2	A_PRE_pool_1.3	A_PRE_pool_2.1	A_PRE_pool_2.2	A_PRE_pool_2.3	A_PRE_pool_3.1	A_PRE_pool_3.2	A_PRE_pool_3.3	F_PRE_pool_0.1	F_PRE_pool_0.2	F_PRE_pool_0.3	F_PRE_pool_1.1	F_PRE_pool_1.2	F_PRE_pool_1.3	F_PRE_pool_2.1	F_PRE_pool_2.2	F_PRE_pool_2.3	F_PRE_pool_3.1	F_PRE_pool_3.2	F_PRE_pool_3.3	A_POST_pool_1.1	A_POST_pool_1.2	A_POST_pool_1.3	A_POST_pool_2.1	A_POST_pool_2.2	A_POST_pool_2.3	A_POST_pool_3.1	A_POST_pool_3.2	A_POST_pool_3.3	F_POST_pool_1.1	F_POST_pool_1.2	F_POST_pool_1.3	F_POST_pool_2.1	F_POST_pool_2.2	F_POST_pool_2.3	F_POST_pool_3.1	F_POST_pool_3.2	F_POST_pool_3.3
Factors	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed	Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed
LPA 18:1	5332581	6728415	6169662	10602407	7858667	8554394	34908976	29351025	24920684	213152586	198726677	225066408	33331	24147	29381	329487	416904	295711	2939122	3487477	4165352	49734662	40558575	39486049	11677171	8749481	9579299	42070071	38098065	34586919	344148432	358988274	379400893	3065377	3269661	3144931	32580459	31418831	34040438	295880063	291045821	259858095
PA 17:0_17:0	836019	686461	505664	1515346	1706988	1404531	15824779	15260202	15224684	137672714	124459064	152097932	1269311	946591	780709	1378430	1471309	1294683	8387086	8940444	9271386	85542552	92009514	89424219	1019469	756897	853616	9515416	9721016	8219428	75153155	72475496	89912800	3336899	2913708	2582018	15434136	16434298	17639063	103843968	92891520	92395037
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	m/z	RT_min
LPA 18:1	435.2517	7.9
PA 17:0_17:0	675.497	19.9
METABOLITES_END
#END